| CAT No: | CL-OCTN-NO-05 |
| CAS No: | NA |
| Mol.F: | C13H17N5O4S |
| Mol.Wt.: | 339.37 |
| Chemical Name: | ((1r,4r)-4-(nitroso(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to N-Nitroso-Oclacitinib impurity 5 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso-Oclacitinib impurity 5 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:((1r,4r)-4-(nitroso(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonic acid Country of Origin: India Product Category: Impurity Reference StandardAPI NAME: Oclacitinib Molecular Formula: C13H17N5O4S
Molecular Weight: 339.37
Storage: Store in a cool, dry place.
| Product Name: | N-Nitroso-Oclacitinib impurity 5 |
| CAS No: | |
| Mol.F.: | C13H17N5O4S |
| Mol.Wt.: | 339.37 |
Cat. No: CL-OCTN-NO-02
CAS No: NA
Mol. F: C15H22N6O3S
Mol. Wt: 366.44
Inv. Status: Custom Synthesis
Cat. No: CL-OCTN-NO-03
CAS No: NA
Mol. F: C14H20N6O3S
Mol. Wt: 352.41
Inv. Status: Custom Synthesis
Cat. No: CL-OCTN-NO-04
CAS No: NA
Mol. F: C14H19N5O4S
Mol. Wt: 353.4
Inv. Status: Custom Synthesis
Cat. No: CL-OCTN-NO-01
CAS No: NA
Mol. F: C15H22N6O3S
Mol. Wt: 366.44
Inv. Status: Custom Synthesis
Cat. No: CL-OCTN-01
CAS No: 1208319-27-0
Mol. F: NA
Mol. Wt: C15H23N5O2S : X(C4H4O4)
Inv. Status: Custom Synthesis
Cat. No: CL-OCTN-02
CAS No: 2124221-13-0
Mol. F: NA
Mol. Wt: C14H20N4O3S
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: